Counting the neurological cost of COVID-19.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

13 citing papers in PubMed.

1. Neurological complications caused by SARS-CoV-2.Clinical microbiology reviews · 2024
   Review
2. COVID-19 and Vestibular Symptoms and Assessment: A Review.Audiology & neuro-otology · 2024
   Review
3. Biosafety and mental health: Virus induced cognitive decline.Biosafety and health · 2023
   Review
4. Emerging evidence of neuronal cells-targeting SARS-CoV-2 causing anosmia associated with COVID-19.Neural regeneration research · 2023
   Article
5. Estrogens as a Possible Therapeutic Strategy for the Management of Neuroinflammation and Neuroprotection in COVID-19.Current neuropharmacology · 2023
   Article
6. Brain fog as a Long-term Sequela of COVID-19.SN comprehensive clinical medicine · 2023
   Review
7. Impairment of central language processing in critically ill coronavirus disease 2019 patients with delirium.Brain communications · 2023
   Article
8. Infectious diseases and cognition: do we have to worry?Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2022
   Review
9. Autoimmunity and SARS-CoV-2 infection: Unraveling the link in neurological disorders.European journal of immunology · 2022
   Review
10. Long-term neuromuscular consequences of SARS-Cov-2 and their similarities with myalgic encephalomyelitis/chronic fatigue syndrome: results of the retrospective CoLGEM study.Journal of translational medicine · 2022
    Observational
11. Long-term outcomes of pediatric infections: from traditional infectious diseases to long Covid.Future microbiology · 2022
    Review
12. COVID-19 at a Glance: An Up-to-Date Overview on Variants, Drug Design and Therapies.Viruses · 2022
    Review
13. Neurological manifestations of long-COVID syndrome: a narrative review.Therapeutic advances in chronic disease · 2022
    Review

Corrections and comments

• Comment on
  Autoimmune Encephalitis After SARS-CoV-2 Infection: Case Frequency, Findings, and Outcomes.2021
• Comment on
  Frequency of Neurologic Manifestations in COVID-19: A Systematic Review and Meta-analysis.2021

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as